24.4 C
New York
Friday, June 12, 2026

Tag: dna

Infinix HOT 60 Pro+ Officially Launches, Setting a New Global Record for the World’s Slimmest 3D-Curved Screen Phone

HONG KONG, July 25, 2025 /PRNewswire/ -- Infinix today unveiled its latest HOT 60 Series lineup, including the HOT 60 Pro+, HOT 60 Pro, HOT...

Infinix HOT 60 Pro+ Officially Launches, Setting a New Global Record for the World’s Slimmest 3D-Curved Screen Phone

HONG KONG, July 25, 2025 /PRNewswire/ -- Infinix today unveiled its latest HOT 60 Series lineup, including the HOT 60 Pro+, HOT 60 Pro, HOT...

CLÉ DE PEAU BEAUTÉ WELCOMES NICOLE KIDMAN AS NEW GLOBAL BRAND AMBASSADOR

The critically acclaimed, award-winning Hollywood actor and producer joins the luxury beauty brand, embodying its philosophy of Radiance. Introducing Nicole Kidman, Clé de Peau Beauté's...

CLÉ DE PEAU BEAUTÉ WELCOMES NICOLE KIDMAN AS NEW GLOBAL BRAND AMBASSADOR

The critically acclaimed, award-winning Hollywood actor and producer joins the luxury beauty brand, embodying its philosophy of Radiance. TOKYO, July 24, 2025 /CNW/ -- Clé...

CLÉ DE PEAU BEAUTÉ WELCOMES NICOLE KIDMAN AS NEW GLOBAL BRAND AMBASSADOR

The critically acclaimed, award-winning Hollywood actor and producer joins the luxury beauty brand, embodying its philosophy of Radiance. TOKYO, July 25, 2025 /PRNewswire/ -- Clé...

CLÉ DE PEAU BEAUTÉ WELCOMES NICOLE KIDMAN AS NEW GLOBAL BRAND AMBASSADOR

The critically acclaimed, award-winning Hollywood actor and producer joins the luxury beauty brand, embodying its philosophy of Radiance. TOKYO, July 24, 2025 /PRNewswire/ -- Clé...

CLÉ DE PEAU BEAUTÉ WELCOMES NICOLE KIDMAN AS NEW GLOBAL BRAND AMBASSADOR

The critically acclaimed, award-winning Hollywood actor and producer joins the luxury beauty brand, embodying its philosophy of Radiance. TOKYO, July 25, 2025 /PRNewswire/ -- Clé...

Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Company to Pursue Technologies to Improve Muscle Strength, Bone Health, and Other Longevity Indicators NEW YORK, July 24, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO)...

PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

Study reveals millions of previously unknown variants and genomic sequences from underrepresented populations
Study reveals millions of previously unknown variants and genomic sequences from underrepresented populations

Aicuris Enrolled Last Participant in Pivotal Trial with Pritelivir to Treat Refractory Herpes Simplex Infection in Immunocompromised Patients

Wuppertal, Germany, July 24, 2025 - Aicuris Anti-infective Cures AG today announced the completion of patient enrollment in its pivotal Phase 3 trial, PRIOH-1, evaluating pritelivir for the treatment of refractory and/or treatment resistant herpes simplex virus (HSV) infections in immunocompromised patients. The company’s lead candidate is a small molecule specifically inhibiting the viral helicase-primase complex, which represents a novel mechanism of action distinct from current HSV therapies.

Xinhua Silk Road: China’s TISCO leads green and low-carbon development in steel industry

BEIJING, July 23, 2025 /PRNewswire/ -- In recent years, Taiyuan Iron and Steel (Group) or TISCO, a subsidiary of China Baowu Steel Group Corporation,...

Xinhua Silk Road: China’s TISCO leads green and low-carbon development in steel industry

BEIJING, July 23, 2025 /CNW/ -- In recent years, Taiyuan Iron and Steel (Group) or TISCO, a subsidiary of China Baowu Steel Group Corporation,...

Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening

Compounds developed through collaboration with Variational AI show targeted activity
Compounds developed through collaboration with Variational AI show targeted activity

IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADC

Clinical efficacy and safety data will be presented from over 70 small-cell lung cancer (SCLC) patients in Hengrui's ongoing, multi-site, open label Phase 1...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDna